PCI president Montu Patel loses Gujarat state pharmacy council membership

Ahmedabad: The Health and Family Welfare Department has removed Montu Kumar Patel from the Gujarat State Pharmacy Council, raising questions about his continuation as president of the Pharmacy Council of India (PCI). The action follows a July 23 order from the administration of Daman & Diu and Dadra & Nagar Haveli, which cancelled Patel’s nomination and removed him from the council.

According to Medical Dialogues reports, the notification issued by the department serves as the first step in the process to remove Patel from his position as PCI president by cancelling his primary membership in the Gujarat State Pharmacy Council. The department’s action formally initiates administrative proceedings that may affect his current role at the national council.

Patel, elected PCI president in 2022, was also serving as the president of the Gujarat State Pharmacy Council. In July, he came under investigation by the Central Bureau of Investigation (CBI) after raids were conducted at his residence in Ahmedabad.

The CBI probe concerns allegations that Patel granted approvals to pharmacy colleges in exchange for bribes, manipulated inspection procedures, and issued irregular recognitions to institutions.

Documents and financial records were seized during the raids, and the investigation has been expanded to other states. Medical Dialogues reported that these developments have increased scrutiny of PCI’s operations.

SC notes procedural lapses by PCI

The removal of Patel follows earlier criticism of PCI. In May, the Supreme Court had noted that the council rejected pharmacy college approvals without following due process and directed adherence to prescribed guidelines.

The developments coincide with ongoing discussions on reforms in pharmacy education regulation, including approval procedures, inspections, and recognition issuance.

According to DeshGujarat, the Health and Family Welfare Department has formally started the procedure to remove Patel as PCI president by cancelling his primary membership in the Gujarat State Pharmacy Council. These administrative and legal steps indicate that PCI leadership may change as investigations and review of council processes continue.

Related Posts

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

New Delhi: Alembic Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Levothyroxine Sodium Tablets USP in…

STF busts fake meds racket spread across 6 states

Dehradun: Uttarakhand special task force (STF) on Friday busted an online fake medicine racket operating through a Facebook page that allegedly sold counterfeit drugs, including cancer medicines, at discounts of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states

All the Way from Teeth to Tee: Hole in One

All the Way from Teeth to Tee: Hole in One

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug